These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2282416)

  • 41. Treatment of AIDS and its attendant malignancies.
    Volberding PA; Kaplan LD
    Prog Clin Biol Res; 1989; 288():459-70. PubMed ID: 2654959
    [No Abstract]   [Full Text] [Related]  

  • 42. Zidovudine in symptomless HIV infection.
    Lancet; 1989 Feb; 1(8635):415-6. PubMed ID: 2563790
    [No Abstract]   [Full Text] [Related]  

  • 43. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.
    Aboulker JP; Swart AM
    Lancet; 1993 Apr; 341(8849):889-90. PubMed ID: 8096582
    [No Abstract]   [Full Text] [Related]  

  • 44. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.
    Pedersen C; Ingeberg S; Teglbjaerg LS
    AIDS; 1989 Nov; 3(11):743-6. PubMed ID: 2515880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Fischl MA; Parker CB; Pettinelli C; Wulfsohn M; Hirsch MS; Collier AC; Antoniskis D; Ho M; Richman DD; Fuchs E
    N Engl J Med; 1990 Oct; 323(15):1009-14. PubMed ID: 1977079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Management of pregnant women with human immunodeficiency virus (HIV) infection].
    Figueroa Damián R
    Ginecol Obstet Mex; 1995 May; 63():173. PubMed ID: 7789842
    [No Abstract]   [Full Text] [Related]  

  • 48. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889
    [No Abstract]   [Full Text] [Related]  

  • 49. Patients' views on the least acceptable increase in survival with zidovudine treatment.
    Gøtzsche PC
    Scand J Infect Dis; 1991; 23(4):509-10. PubMed ID: 1957136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
    Cox PH; Martin MA; Styer CM; Beall GN
    Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDA expands testing of anti-AIDS drugs.
    N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ocular pathology in HIV infection].
    Melino G; Cruciani F; Mazzarino R
    Clin Ter; 1992 Sep; 141(9):187-92. PubMed ID: 1458804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
    Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
    J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Labeling revised for longterm dosage of AZT.
    J Am Osteopath Assoc; 1990 Jun; 90(6):487. PubMed ID: 2351577
    [No Abstract]   [Full Text] [Related]  

  • 55. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Epidemiological news on infectious diseases].
    Vella S; Rocchi G
    Medicina (Firenze); 1988; 8(2):233-4. PubMed ID: 2852294
    [No Abstract]   [Full Text] [Related]  

  • 57. AZT for children with AIDS.
    Engel NS
    MCN Am J Matern Child Nurs; 1989; 14(2):121. PubMed ID: 2495409
    [No Abstract]   [Full Text] [Related]  

  • 58. Nail dyschromia associated with zidovudine.
    Don PC; Fusco F; Fried P; Batterman A; Duncanson FP; Lenox TH; Klein NC
    Ann Intern Med; 1990 Jan; 112(2):145-6. PubMed ID: 2294820
    [No Abstract]   [Full Text] [Related]  

  • 59. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity.
    Warrier I; Lusher JM
    Am J Pediatr Hematol Oncol; 1990; 12(2):160-3. PubMed ID: 2378412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.